Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma
D'UN CANCER DU PANCREAS EXOCRINE RESECABLE OU POTENTIELLEMENT RESECABLE. : UNE COHORTE PROSPECTIVE MULTICENTRIQUE (PANCREAS CGE). Promoteur : CHU Besançon.
Virginia Mason Franciscan Health Bulletin Winter 2024Similarly to breast cancer, pancreatic ductal adenocarcinoma (PDAC) tumors 99 have a significant amount of extra-cellular matrix components ... Molecular Mechanisms and Therapies of Pancreatic Cancer - MDPI? Pamrevlumab can potentially be used in a broad range of DMD patients ... LAPC - Locally Advanced Pancreatic Cancer. MDS - Myelodysplastic Syndrome. 36 ... Thérapie de la myopathie de Duchenne de Boulogne - DUMASPancreatic Cancer (LAPC). Metastatic Pancreatic Cancer. 1H 2024. TBD. Duchenne ... ? Pamrevlumab can potentially be used in a broad range of DMD patients ...
Autres Cours:
